<code id='067D5D0CA6'></code><style id='067D5D0CA6'></style>
    • <acronym id='067D5D0CA6'></acronym>
      <center id='067D5D0CA6'><center id='067D5D0CA6'><tfoot id='067D5D0CA6'></tfoot></center><abbr id='067D5D0CA6'><dir id='067D5D0CA6'><tfoot id='067D5D0CA6'></tfoot><noframes id='067D5D0CA6'>

    • <optgroup id='067D5D0CA6'><strike id='067D5D0CA6'><sup id='067D5D0CA6'></sup></strike><code id='067D5D0CA6'></code></optgroup>
        1. <b id='067D5D0CA6'><label id='067D5D0CA6'><select id='067D5D0CA6'><dt id='067D5D0CA6'><span id='067D5D0CA6'></span></dt></select></label></b><u id='067D5D0CA6'></u>
          <i id='067D5D0CA6'><strike id='067D5D0CA6'><tt id='067D5D0CA6'><pre id='067D5D0CA6'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:comprehensive    Page View:61

          Editor’s note: A recording of the event is embedded below.

          After a few go-go years, the early-stage biotech market has cooled considerably. Two VCs will weigh in on what distinguishes great science from bad investments.

          advertisement

          Featured Speakers

          • Irena Melnikova, Ph.D., partner, Pfizer Ventures
          • Rakhshita Dhar, senior director, venture investments, Leaps by Bayer
          • Frank S. David, M.D., Ph.D., managing director, Pharmagellan (moderator)

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more
          Trump Jan. 6 attorney John Lauro is ex
          Trump Jan. 6 attorney John Lauro is ex

          9:45SplitimagefeaturingattorneyforformerPresidentDonaldTrump,JohnLauro,speakstoABC'sGeorgeStephanopo

          read more
          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more

          St. Louis police protesters begin picking up checks in $4.9 million settlement

          FILE-ProtestersgatherinSt.Louis,Sept.15,2017,afterajudgefoundawhiteformerSt.Louispoliceofficer,Jason